Avelox

Medicinal product

(Invented) name

Avelox

Active substance (s)

Moksifloksacinas

Strength

400 mg/250 ml

Pharmaceutical form

infuzinis tirpalas

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J01MA14, Moxifloxacin

Marketing authorisation holder

Bayer AG, Vokietija

Date of authorisation

2004-10-12

Date of renewal

2014-10-27

Documents

0126 Pakuotės lapelis 2025 02 19.docx

0126 Avelox inf PCS PL 2025 02 19.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10a

Procedure number

DE/H/0155/002/E/003

Marketing authorisation procedure

Kartotinė procedūra

Qualitative and quantitative composition

Buteliuke arba maišelyje (250 ml) yra	250 ml
Moksifloksacinas	400 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
12330	16712	1016712	buteliukas	250 ml N1		Receptinis	LT/1/04/0126/004	Tiekiama	-	-	No	-	-	Download
14442	18689	1018689	buteliukas	250 ml N5		Receptinis	LT/1/04/0126/005	Netiekiama	-	-	No	-	-
14443	18690	1018690	maišelis	250 ml N5		Receptinis	LT/1/04/0126/006	Netiekiama	-	-	No	-	-
14444	18691	1018691	maišelis	250 ml N12		Receptinis	LT/1/04/0126/007	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2014-10-27	Perregistruotas
2004-10-12	Registruotas